The following post was written by Ben Carlson from A Wealth of Common Sense.
Baron Rothchild once said that “The time to buy is when there’s blood in the streets.” Does that mean it’s time to start looking to rebalance into emerging markets?
Investors have soured on emerging market stocks this year. Growth is slowing in these countries, even though it remains higher than the developed economies. Inflation and volatility are rising, and the general sentiment is just plain lousy.
No one wants to invest in the developing economies of the world right now. I think this could be an opportunity for investors who are comfortable with higher levels of volatility in their portfolios.
Things could definitely worsen before they get better, but contrarian or value investors are usually early to buy and sell. Since the price you pay for investment has such a large impact on your final returns, buying undervalued assets when they are hated has been a successful strategy in the past.
From the beginning of 2011 through August 2013, emerging market stocks, as measured by the Vanguard EM ETF (VWO), are down 16.89%, while US stocks, as measured by the Vanguard Total Stock Market ETF (VTI), are up a collective 37.38%. This year alone, VWO is down -14.01% through August, even though VTI is up 16.77%.
This huge divergence had happened in the past, most recently in the late 1990s when there was a currency crisis in the EM markets. The current trailing one-year P/E ratio for the emerging market stocks is about a 60% discount to the P/E of the S&P 500.
GMO 7-Year Forecast
Well-respected investment management firm GMO recently put out their 7-year forecast of real (after-inflation) returns for stocks and bonds along with various sub-strategies within each asset class. Here’s what they came up with:
Obviously, GMO is not big on US stocks after the large run-up since 2009. These numbers are based purely on fundamentals and valuations based on historical relationships and GMO’s future outlook.
I’m a big believer in the fact that no one can predict the future, especially of a financial variety, but GMO has been fairly accurate with their long-term calls in the past. You’ll notice that this is not a forecast for the next 3 months or even the next year. Those kinds of predictions are about as accurate as your local weatherman making a forecast for next spring.
I can’t promise that buying Emerging Market stocks will be the right move now or next year, but buying hated asset classes when they are undervalued has been a winning strategy in the past.
Investing in Emerging Market ETFs
Since these stocks are spread across multiple countries, ETFs are the easiest way to get broadly diversified exposure. This is far less risky and much less expensive than trading on a foreign stock market directly. Although many discount brokers offer global trading, the ETF route is a much better way to go.
The Vanguard FTSE Emerging Markets ETF (VWO) holds almost 1,000 different companies spread throughout the various countries that make up the FTSE Emerging Markets Index.
Another interesting ETF for yield-hungry investors is the iShares Emerging Markets Dividend ETF (ticker DVYE). This ETF is made up of over 100 of the top dividend-paying stocks throughout the emerging markets. The current yield is over 4%, and like VWO, this ETF is also down about 14% year to date.
Know the Risks
Just remember that historically emerging market stocks have had roughly double the volatility of the S&P 500, so investing in them requires the ability to look past short-term unpredictability. They also offer lower correlation to the developed markets, meaning they could zig while other markets zag. Investing in uncorrelated assets can actually smooth your returns over longer periods and allow you to rebalance to those areas of your portfolio that are lagging.
Emerging market stocks were up over 7% in September but look relatively cheap compared to other global markets and offer good long-term value. For those nervous about trying to catch a falling knife, you can always average into your purchases over a few months or quarters to spread your risk.
Disclosure: At the time of this writing, the author held a position in DVYE.